Published Healthcare & Pharmaceuticals Type 1 Diabetes Treatment A humanized monoclonal antibody against Serpin B13 to treat Type 1 Diabetes. By University of Minnesota
Published Medical Vaccine Against Type1 Diabetes Novel immune response against the protease inhibitor Serpin B13, which both suppresses T-cell mediated autoimmune inflammation and enhances beta cell survival. By David Englert
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
